Oncothyreon
Seattle, US
Founders & leadership
SP
Scott PetersonExecutive
GC
Gary ChristiansonExecutive
DH
Diana HausmanExecutive
RL
Robert L. KirkmanExecutive
JE
Julia EastlandExecutive
JV
Jay VenkatesanExecutive
Board
RJ
Richard JacksonBoard director
TW
Ted W. LoveBoard director
DS
Daniel SpiegelmanBoard director
WV
W. Vickery StoughtonBoard director
CH
Christopher HenneyBoard director
Reported raises · per SEC filings
Form D private placements$22.9M disclosed across 1 round · 2014
▶$22.9MraisedAug 2014 · 5 investors · BiotechnologyRule 506(b)
▶$22.9MraisedAug 2014 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Scott PetersonExecutive Officer
- Gary ChristiansonExecutive Officer
- Richard JacksonDirector
- Ted W. LoveDirector
- Diana HausmanExecutive Officer
- Robert L. KirkmanExecutive Officer, Director
- Julia EastlandExecutive Officer
- Daniel SpiegelmanDirector
- W. Vickery StoughtonDirector
- Jay VenkatesanExecutive Officer
- Christopher HenneyDirector
- Offering amount
- $22.9M
- Amount sold
- $22.9M
- First sale
- Aug 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Oncothyreon raised?
- Oncothyreon has disclosed $22.9M raised across 1 round.
- Where is Oncothyreon headquartered?
- Oncothyreon is headquartered in Seattle, US.